These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30239743)

  • 1. Effect of aminoacyl-tRNA synthetase mutations on susceptibility to ciprofloxacin in Escherichia coli.
    Garoff L; Huseby DL; Praski Alzrigat L; Hughes D
    J Antimicrob Chemother; 2018 Dec; 73(12):3285-3292. PubMed ID: 30239743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciprofloxacin selects for RNA polymerase mutations with pleiotropic antibiotic resistance effects.
    Pietsch F; Bergman JM; Brandis G; Marcusson LL; Zorzet A; Huseby DL; Hughes D
    J Antimicrob Chemother; 2017 Jan; 72(1):75-84. PubMed ID: 27621175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli.
    Praski Alzrigat L; Huseby DL; Brandis G; Hughes D
    J Antimicrob Chemother; 2017 Nov; 72(11):3016-3024. PubMed ID: 28962020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of AcrEF in Quinolone Resistance Development in Escherichia coli When AcrAB-TolC Function Is Impaired.
    Zhang CZ; Chang MX; Yang L; Liu YY; Chen PX; Jiang HX
    Microb Drug Resist; 2018; 24(1):18-23. PubMed ID: 28520511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations That Enhance the Ciprofloxacin Resistance of Escherichia coli with qnrA1.
    Vinué L; Corcoran MA; Hooper DC; Jacoby GA
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1537-45. PubMed ID: 26711751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simulated microgravity affects ciprofloxacin susceptibility and expression of acrAB-tolC genes in E. coli ATCC25922.
    Xu B; Li C; Zheng Y; Si S; Shi Y; Huang Y; Zhang J; Cui Y; Cui Y
    Int J Clin Exp Pathol; 2015; 8(7):7945-52. PubMed ID: 26339360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total alkaloids of Sophorea alopecuroides-induced down-regulation of AcrAB-TolC efflux pump reverses susceptibility to ciprofloxacin in clinical multidrug resistant Escherichia coli isolates.
    Zhou X; Jia F; Liu X; Wang Y
    Phytother Res; 2012 Nov; 26(11):1637-43. PubMed ID: 22371352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of the potential of the multiple antibiotic resistance operon (mar) and the multidrug efflux pump acrAB to moderate resistance towards ciprofloxacin in Escherichia coli biofilms.
    Maira-Litrán T; Allison DG; Gilbert P
    J Antimicrob Chemother; 2000 Jun; 45(6):789-95. PubMed ID: 10837431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance in Escherichia coli: variable contribution of efflux pumps with respect to different fluoroquinolones.
    Huguet A; Pensec J; Soumet C
    J Appl Microbiol; 2013 May; 114(5):1294-9. PubMed ID: 23414263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance/fitness trade-off is a barrier to the evolution of MarR inactivation mutants in Escherichia coli.
    Praski Alzrigat L; Huseby DL; Brandis G; Hughes D
    J Antimicrob Chemother; 2021 Jan; 76(1):77-83. PubMed ID: 33089314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal mutations that accompany qnr in clinical isolates of Escherichia coli.
    Vinué L; Hooper DC; Jacoby GA
    Int J Antimicrob Agents; 2018 Mar; 51(3):479-483. PubMed ID: 29360506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. tRNA synthetase mutants of Escherichia coli K-12 are resistant to the gyrase inhibitor novobiocin.
    Jovanovic M; Lilic M; Janjusevic R; Jovanovic G; Savic DJ
    J Bacteriol; 1999 May; 181(9):2979-83. PubMed ID: 10217798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of AcrAB-TolC Efflux Pumps on Quinolone Resistance of E. coli ST131.
    Atac N; Kurt-Azap O; Dolapci I; Yesilkaya A; Ergonul O; Gonen M; Can F
    Curr Microbiol; 2018 Dec; 75(12):1661-1666. PubMed ID: 30283991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of Antibiotic Efflux Machinery in Glutathione-Mediated Decreased Ciprofloxacin Activity in Escherichia coli.
    Goswami M; Subramanian M; Kumar R; Jass J; Jawali N
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4369-74. PubMed ID: 27139480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro selection of resistance to pradofloxacin and ciprofloxacin in canine uropathogenic Escherichia coli isolates.
    Liu X; Lazzaroni C; Aly SA; Thungrat K; Boothe DM
    Vet Microbiol; 2014 Dec; 174(3-4):514-522. PubMed ID: 25465666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De Novo Characterization of Genes That Contribute to High-Level Ciprofloxacin Resistance in Escherichia coli.
    Tran T; Ran Q; Ostrer L; Khodursky A
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6353-5. PubMed ID: 27431218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tigecycline Nonsusceptibility Occurs Exclusively in Fluoroquinolone-Resistant Escherichia coli Clinical Isolates, Including the Major Multidrug-Resistant Lineages O25b:H4-ST131-H30R and O1-ST648.
    Sato T; Suzuki Y; Shiraishi T; Honda H; Shinagawa M; Yamamoto S; Ogasawara N; Takahashi H; Takahashi S; Tamura Y; Yokota SI
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation Supply and Relative Fitness Shape the Genotypes of Ciprofloxacin-Resistant Escherichia coli.
    Huseby DL; Pietsch F; Brandis G; Garoff L; Tegehall A; Hughes D
    Mol Biol Evol; 2017 May; 34(5):1029-1039. PubMed ID: 28087782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of VceC gain-of-function mutants that can function with the AcrAB multiple-drug-resistant efflux pump of Escherichia coli.
    Vediyappan G; Borisova T; Fralick JA
    J Bacteriol; 2006 Jun; 188(11):3757-62. PubMed ID: 16707668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country.
    Christiansen N; Nielsen L; Jakobsen L; Stegger M; Hansen LH; Frimodt-Møller N
    Microb Drug Resist; 2011 Sep; 17(3):395-406. PubMed ID: 21668371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.